Laduviglusib (CHIR-99021)
Laduviglusib (CHIR-99021, CT99021) is a GSK-3α and GSK-3β inhibitor with IC50 of 10 nM and 6.7 nM, respectively. CHIR99201 does not exhibit cross-reactivity against cyclin-dependent kinases (CDKs) and shows a 350-fold selectivity toward GSK-3β compared to CDKs. CHIR99021 functions as a Wnt/β-catenin activator and induces autophagy.
Supplier | Selleck Chemicals |
---|---|
Product # | S1263 |
Sku # | S1263-100mg |
Pricing | 100mg, $970.00 |
Citations for this product:
-
bioRxiv - Cell Biology 2020Quote: ... 3μM CHIR99021 (Selleck Chemicals, S1263), and 100ng/mL recombinant murine TNFα (Peprotech ...
-
bioRxiv - Developmental Biology 2022Quote: ... CHIR-99021 = 1 μM (Selleck Chemicals; Houston, TX; Cat# S1263) or DMSO (control ...
-
bioRxiv - Pharmacology and Toxicology 2023Quote: ... Three additional small molecule inhibitors consisting of CHIR99021 (3 μM, S1263, Selleck Chemicals), SU5402 (10 μM ...